Medtronic plc (NYSE: MDT), a global healthcare technology leader, announced the first patient enrolled in the Expand URO U.S. clinical trial for the Hugo™ robotic-assisted surgery (RAS) surgery. The robotic-assisted prostatectomy procedure was performed by Michael Abern, MD, Associate Professor of Surgery, Division of Urology.
Congratulations to Dr. Abern on this accomplishment of performing the first U.S. clinical trial case using Hugo™.
Learn more about the procedure and clinical trail on PR Newswire.